MSH2 and glioblastoma: Knockdown of MSH2, resulting in a 60% decrease in MMR activity (Fig. S15), rendered cells completely resistant to TMZ, consistent with previous reports that even a partial loss of MMR imparts substantial TMZ resistance in GBM cells19.